866-997-4948(US-Canada Toll Free)

United States Hepatitis C Drug Market Report 2017

Published By :

QYResearch

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 101 Pages

In this report, the United States Hepatitis C Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Hepatitis C Drug in these regions, from 2012 to 2022 (forecast).

United States Hepatitis C Drug market competition by top manufacturers/players, with Hepatitis C Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Merck & Co
Kenilworth
Roche
Basel GlaxoSmith
Gilead Sciences
AbbVie
Johnson & Johnson
Bristol-Myers Squibb

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Oral
Injection
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Hepatitis C Drug for each application, including
Hospitals
Private Labs
Physician Offices
Public Health Labs
Blood Bank

Table of Contents

United States Hepatitis C Drug Market Report 2017
1 Hepatitis C Drug Overview
1.1 Product Overview and Scope of Hepatitis C Drug
1.2 Classification of Hepatitis C Drug by Product Category
1.2.1 United States Hepatitis C Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Hepatitis C Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Oral
1.2.4 Injection
1.2.5 Other
1.3 United States Hepatitis C Drug Market by Application/End Users
1.3.1 United States Hepatitis C Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Private Labs
1.3.4 Physician Offices
1.3.5 Public Health Labs
1.3.6 Blood Bank
1.4 United States Hepatitis C Drug Market by Region
1.4.1 United States Hepatitis C Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Hepatitis C Drug Status and Prospect (2012-2022)
1.4.3 Southwest Hepatitis C Drug Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Hepatitis C Drug Status and Prospect (2012-2022)
1.4.5 New England Hepatitis C Drug Status and Prospect (2012-2022)
1.4.6 The South Hepatitis C Drug Status and Prospect (2012-2022)
1.4.7 The Midwest Hepatitis C Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Hepatitis C Drug (2012-2022)
1.5.1 United States Hepatitis C Drug Sales and Growth Rate (2012-2022)
1.5.2 United States Hepatitis C Drug Revenue and Growth Rate (2012-2022)

2 United States Hepatitis C Drug Market Competition by Players/Suppliers
2.1 United States Hepatitis C Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Hepatitis C Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Hepatitis C Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Hepatitis C Drug Market Competitive Situation and Trends
2.4.1 United States Hepatitis C Drug Market Concentration Rate
2.4.2 United States Hepatitis C Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hepatitis C Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Hepatitis C Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Hepatitis C Drug Sales and Market Share by Region (2012-2017)
3.2 United States Hepatitis C Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Hepatitis C Drug Price by Region (2012-2017)

4 United States Hepatitis C Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Hepatitis C Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Hepatitis C Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Hepatitis C Drug Price by Type (2012-2017)
4.4 United States Hepatitis C Drug Sales Growth Rate by Type (2012-2017)

5 United States Hepatitis C Drug Sales (Volume) by Application (2012-2017)
5.1 United States Hepatitis C Drug Sales and Market Share by Application (2012-2017)
5.2 United States Hepatitis C Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Hepatitis C Drug Players/Suppliers Profiles and Sales Data
6.1 Merck & Co
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Hepatitis C Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck & Co Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Kenilworth
6.2.2 Hepatitis C Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Kenilworth Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Roche
6.3.2 Hepatitis C Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Roche Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Basel GlaxoSmith
6.4.2 Hepatitis C Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Basel GlaxoSmith Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Gilead Sciences
6.5.2 Hepatitis C Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Gilead Sciences Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 AbbVie
6.6.2 Hepatitis C Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AbbVie Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
6.7.2 Hepatitis C Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Johnson & Johnson Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb
6.8.2 Hepatitis C Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bristol-Myers Squibb Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview

7 Hepatitis C Drug Manufacturing Cost Analysis
7.1 Hepatitis C Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hepatitis C Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Hepatitis C Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hepatitis C Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Hepatitis C Drug Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Hepatitis C Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Hepatitis C Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Hepatitis C Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Hepatitis C Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Hepatitis C Drug
Figure United States Hepatitis C Drug Market Size (K Units) by Type (2012-2022)
Figure United States Hepatitis C Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Injection Product Picture
Figure Other Product Picture
Figure United States Hepatitis C Drug Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Hepatitis C Drug by Application in 2016
Figure Hospitals Examples
Figure Private Labs Examples
Figure Physician Offices Examples
Figure Public Health Labs Examples
Figure Blood Bank Examples
Figure United States Hepatitis C Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Hepatitis C Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Hepatitis C Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Hepatitis C Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Hepatitis C Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Hepatitis C Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Hepatitis C Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatitis C Drug Sales (K Units) and Growth Rate (2012-2022)
Figure United States Hepatitis C Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatitis C Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Hepatitis C Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Hepatitis C Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatitis C Drug Sales Share by Players/Suppliers
Figure 2017 United States Hepatitis C Drug Sales Share by Players/Suppliers
Figure United States Hepatitis C Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Hepatitis C Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Hepatitis C Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatitis C Drug Revenue Share by Players/Suppliers
Figure 2017 United States Hepatitis C Drug Revenue Share by Players/Suppliers
Table United States Market Hepatitis C Drug Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Hepatitis C Drug Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Hepatitis C Drug Market Share of Top 3 Players/Suppliers
Figure United States Hepatitis C Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hepatitis C Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hepatitis C Drug Product Category
Table United States Hepatitis C Drug Sales (K Units) by Region (2012-2017)
Table United States Hepatitis C Drug Sales Share by Region (2012-2017)
Figure United States Hepatitis C Drug Sales Share by Region (2012-2017)
Figure United States Hepatitis C Drug Sales Market Share by Region in 2016
Table United States Hepatitis C Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Hepatitis C Drug Revenue Share by Region (2012-2017)
Figure United States Hepatitis C Drug Revenue Market Share by Region (2012-2017)
Figure United States Hepatitis C Drug Revenue Market Share by Region in 2016
Table United States Hepatitis C Drug Price (USD/Unit) by Region (2012-2017)
Table United States Hepatitis C Drug Sales (K Units) by Type (2012-2017)
Table United States Hepatitis C Drug Sales Share by Type (2012-2017)
Figure United States Hepatitis C Drug Sales Share by Type (2012-2017)
Figure United States Hepatitis C Drug Sales Market Share by Type in 2016
Table United States Hepatitis C Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Hepatitis C Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hepatitis C Drug by Type (2012-2017)
Figure Revenue Market Share of Hepatitis C Drug by Type in 2016
Table United States Hepatitis C Drug Price (USD/Unit) by Types (2012-2017)
Figure United States Hepatitis C Drug Sales Growth Rate by Type (2012-2017)
Table United States Hepatitis C Drug Sales (K Units) by Application (2012-2017)
Table United States Hepatitis C Drug Sales Market Share by Application (2012-2017)
Figure United States Hepatitis C Drug Sales Market Share by Application (2012-2017)
Figure United States Hepatitis C Drug Sales Market Share by Application in 2016
Table United States Hepatitis C Drug Sales Growth Rate by Application (2012-2017)
Figure United States Hepatitis C Drug Sales Growth Rate by Application (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Hepatitis C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co Hepatitis C Drug Sales Growth Rate (2012-2017)
Figure Merck & Co Hepatitis C Drug Sales Market Share in United States (2012-2017)
Figure Merck & Co Hepatitis C Drug Revenue Market Share in United States (2012-2017)
Table Kenilworth Basic Information List
Table Kenilworth Hepatitis C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kenilworth Hepatitis C Drug Sales Growth Rate (2012-2017)
Figure Kenilworth Hepatitis C Drug Sales Market Share in United States (2012-2017)
Figure Kenilworth Hepatitis C Drug Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Hepatitis C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Hepatitis C Drug Sales Growth Rate (2012-2017)
Figure Roche Hepatitis C Drug Sales Market Share in United States (2012-2017)
Figure Roche Hepatitis C Drug Revenue Market Share in United States (2012-2017)
Table Basel GlaxoSmith Basic Information List
Table Basel GlaxoSmith Hepatitis C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Basel GlaxoSmith Hepatitis C Drug Sales Growth Rate (2012-2017)
Figure Basel GlaxoSmith Hepatitis C Drug Sales Market Share in United States (2012-2017)
Figure Basel GlaxoSmith Hepatitis C Drug Revenue Market Share in United States (2012-2017)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Hepatitis C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gilead Sciences Hepatitis C Drug Sales Growth Rate (2012-2017)
Figure Gilead Sciences Hepatitis C Drug Sales Market Share in United States (2012-2017)
Figure Gilead Sciences Hepatitis C Drug Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Hepatitis C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Hepatitis C Drug Sales Growth Rate (2012-2017)
Figure AbbVie Hepatitis C Drug Sales Market Share in United States (2012-2017)
Figure AbbVie Hepatitis C Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Hepatitis C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Hepatitis C Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Hepatitis C Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Hepatitis C Drug Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Hepatitis C Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Hepatitis C Drug Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Hepatitis C Drug Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Hepatitis C Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis C Drug
Figure Manufacturing Process Analysis of Hepatitis C Drug
Figure Hepatitis C Drug Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis C Drug Major Players/Suppliers in 2016
Table Major Buyers of Hepatitis C Drug
Table Distributors/Traders List
Figure United States Hepatitis C Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Hepatitis C Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hepatitis C Drug Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Hepatitis C Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hepatitis C Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hepatitis C Drug Sales Volume (K Units) Forecast by Type in 2022
Table United States Hepatitis C Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hepatitis C Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hepatitis C Drug Sales Volume (K Units) Forecast by Application in 2022
Table United States Hepatitis C Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Hepatitis C Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatitis C Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatitis C Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *